METHADONE HYDROCHLORIDE solution Stany Zjednoczone - angielski - NLM (National Library of Medicine)

methadone hydrochloride solution

specgx llc - methadone hydrochloride (unii: 229809935b) (methadone - unii:uc6vbe7v1z) - methadone hydrochloride oral solution is indicated for the: - management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. limitations of use: because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses, and because of the greater risks of overdose and death with long-acting opioids [ see warnings and precautions (5.2) ] , reserve methadone hydrochloride oral solution for use in patients for whom alternative analgesic treatment options (e.g., non-opioid analgesics or immediate-release opioid analgesics) are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. methadone hydrochloride oral solution is not indicated as an as-needed (prn) analgesic. limitations of use: - because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses, and because of the greater risks of overdose and death with long-acting

NALTREXONE HYDROCHLORIDE tablet, film coated Stany Zjednoczone - angielski - NLM (National Library of Medicine)

naltrexone hydrochloride tablet, film coated

specgx llc - naltrexone hydrochloride (unii: z6375yw9sf) (naltrexone - unii:5s6w795cqm) - naltrexone hydrochloride 50 mg - naltrexone hydrochloride tablets are indicated in the treatment of alcohol dependence and for the blockade of the effects of exogenously administered opioids. naltrexone hydrochloride tablets have not been shown to provide any therapeutic benefit except as part of an appropriate plan of management for the addictions. naltrexone is contraindicated in: 1. patients receiving opioid analgesics. 2. patients currently dependent on opioids, including those currently maintained on opiate agonists (e.g., methadone) or partial agonists (e.g., buprenorphine). 3. patients in acute opioid withdrawal (see warnings ). 4. any individual who has failed the naloxone challenge test or who has a positive urine screen for opioids. 5. any individual with a history of sensitivity to naltrexone or any other components of this product. it is not known if there is any cross-sensitivity with naloxone or the phenanthrene containing opioids. naltrexone is a pure opioid antagonist. it does not lead to physical or psychological depend

4054 Alcohol Antiseptic 80% Stany Zjednoczone - angielski - NLM (National Library of Medicine)

4054 alcohol antiseptic 80%

specgx llc - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antiseptic health care personnel hand rub to help reduce bacteria that potentially can cause disease. for use when soap and water are not available.

4020 Isopropyl Alcohol Antiseptic 75% Stany Zjednoczone - angielski - NLM (National Library of Medicine)

4020 isopropyl alcohol antiseptic 75%

specgx llc - isopropyl alcohol (unii: nd2m416302) (isopropyl alcohol - unii:nd2m416302) - antiseptic hand sanitizer to help reduce bacteria that potentially can cause disease. for use when soap and water are not available.

4021 Alcohol Antiseptic 80% Stany Zjednoczone - angielski - NLM (National Library of Medicine)

4021 alcohol antiseptic 80%

specgx llc - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antiseptic hand sanitizer to help reduce bacteria that potentially can cause disease. for use when soap and water are not available.

4053 Isopropyl Alcohol Antiseptic 75% Stany Zjednoczone - angielski - NLM (National Library of Medicine)

4053 isopropyl alcohol antiseptic 75%

specgx llc - isopropyl alcohol (unii: nd2m416302) (isopropyl alcohol - unii:nd2m416302) - antiseptic health care personnel hand rub to help reduce bacteria that potentially can cause disease. for use when soap and water are not available.

DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE tablet Stany Zjednoczone - angielski - NLM (National Library of Medicine)

diphenoxylate hydrochloride and atropine sulfate tablet

specgx llc - diphenoxylate hydrochloride (unii: w24od7yw48) (diphenoxylate - unii:73312p173g), atropine sulfate (unii: 03j5ze7ka5) (atropine - unii:7c0697dr9i) - diphenoxylate hydrochloride and atropine sulfate tablets are indicated as adjunctive therapy in the management of diarrhea in patients 13 years of age and older. diphenoxylate hydrochloride and atropine sulfate tablets are contraindicated in: - pediatric patients less than 6 years of age due to the risks of respiratory and central nervous system (cns) depression (see warnings ). - patients with diarrhea associated with pseudomembranous enterocolitis (clostridium difficile ) or other enterotoxin-producing bacteria due to the risk of gastrointestinal (gi) complications, including sepsis (see warnings ). - patients with known hypersensitivity to diphenoxylate or atropine. - patients with obstructive jaundice. diphenoxylate hydrochloride and atropine sulfate tablets are classified as a schedule v controlled substance by federal regulation. diphenoxylate hydrochloride is chemically related to the narcotic analgesic meperidine. in doses used for the treatment of diarrhea, whether acute or chronic, diphenoxylate h

METHADOSE DISPERSIBLE- methadone hydrochloride tablet
METHADONE HYDROCHLORIDE tablet Stany Zjednoczone - angielski - NLM (National Library of Medicine)

methadose dispersible- methadone hydrochloride tablet methadone hydrochloride tablet

specgx llc - methadone hydrochloride (unii: 229809935b) (methadone - unii:uc6vbe7v1z) - methadone hydrochloride 40 mg - methadone hydrochloride tablets for oral suspension contain methadone, an opioid agonist indicated for the: - detoxification treatment of opioid addiction (heroin or other morphine-like drugs). - maintenance treatment of opioid addiction (heroin or other morphine-like drugs), in conjunction with appropriate social and medical services. limitations of use methadone products used for the treatment of opioid addiction in detoxification or maintenance programs are subject to the conditions for distribution and use required under 42 cfr 8.12 [see dosage and administration (2.1)] . methadone hydrochloride tablets for oral suspension are contraindicated in patients with: - significant respiratory depression [see warnings and precautions (5.1)]. significant respiratory depression [see warnings and precautions (5.1)]. - acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment [see warnings and precautions (5.8)]. acute or severe bronchial asthma in an unmonitored s

ACETAMINOPHEN AND CODEINE PHOSPHATE tablet Stany Zjednoczone - angielski - NLM (National Library of Medicine)

acetaminophen and codeine phosphate tablet

aidarex pharmaceuticals llc - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j) - acetaminophen and codeine phosphate tablets are indicated for the management of mild to moderate pain, where treatment with an opioid is appropriate and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses (see warnings ), reserve acetaminophen and codeine phosphate tablets for use in patients for whom alternative treatment options (e.g., non-opioid analgesics) - have not provided adequate analgesia, or are not expected to provide adequate analgesia, have not provided adequate analgesia, or are not expected to provide adequate analgesia, - have not been tolerated, or are not expected to be tolerated. acetaminophen and codeine phosphate tablets are contraindicated for: - all children younger than 12 years of age (see  warnings ). - post-operative management in children younger than 18 years of age following tonsillectomy and/or adenoidectomy (see  warnings ). acetaminophen and codeine phosphate table

ACETAMINOPHEN AND CODEINE PHOSPHATE tablet Stany Zjednoczone - angielski - NLM (National Library of Medicine)

acetaminophen and codeine phosphate tablet

cardinal health 107, llc - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j) - acetaminophen 300 mg - acetaminophen and codeine phosphate tablets are indicated for the management of mild to moderate pain, where treatment with an opioid is appropriate and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses (see warnings ), reserve acetaminophen and codeine phosphate tablets for use in patients for whom alternative treatment options (e.g., non-opioid analgesics) acetaminophen and codeine phosphate tablets are contraindicated for: acetaminophen and codeine phosphate tablets are contraindicated in patients with: controlled substance acetaminophen and codeine phosphate tablets contain codeine. codeine in combination with acetaminophen, is a schedule iii controlled substance. abuse acetaminophen and codeine phosphate tablets contain codeine, a substance with a high potential for abuse similar to other opioids, including fentanyl, hydrocodone, hydromorphone, methadone, morphine, oxycodone, oxymorphone, a